US Stock MarketDetailed Quotes

CGON CG Oncology

Watchlist
  • 33.950
  • +0.480+1.43%
Close Nov 25 16:00 ET
  • 33.950
  • 0.0000.00%
Post 16:16 ET
2.30BMarket Cap-29267P/E (TTM)

CG Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
377.78%43K
111K
172.68%529K
6.81%204K
1K
9K
0
194K
-98.16%191K
0
Operating revenue
377.78%43K
--111K
172.68%529K
6.81%204K
--1K
--9K
--0
--194K
-98.16%191K
--0
Cost of revenue
Gross profit
Operating expense
101.67%28.34M
110.64%25.96M
131.95%23M
57.05%55.65M
107.79%19.36M
14.05M
12.33M
9.92M
54.32%35.44M
9.32M
Selling and administrative expenses
276.18%8.72M
200.48%7.49M
179.21%5.79M
54.51%9.9M
82.02%3.02M
--2.32M
--2.49M
--2.07M
37.95%6.41M
--1.66M
-General and administrative expense
276.18%8.72M
200.48%7.49M
179.21%5.79M
54.51%9.9M
82.02%3.02M
--2.32M
--2.49M
--2.07M
37.95%6.41M
--1.66M
Research and development costs
67.21%19.62M
87.86%18.47M
119.46%17.21M
57.61%45.75M
113.37%16.34M
--11.74M
--9.83M
--7.84M
58.46%29.03M
--7.66M
Operating profit
-101.49%-28.3M
-109.74%-25.85M
-131.14%-22.47M
-57.32%-55.45M
-107.78%-19.36M
-14.04M
-12.33M
-9.72M
-179.60%-35.25M
-9.32M
Net non-operating interest income expense
245.69%7.89M
800.52%6.94M
430.21%5.55M
690,500.00%6.9M
208.13%2.8M
2.28M
771K
1.05M
99.78%-1K
910K
Non-operating interest income
245.69%7.89M
800.52%6.94M
430.21%5.55M
----
----
--2.28M
--771K
--1.05M
----
----
Total other finance cost
----
----
----
-690,500.00%-6.9M
----
----
----
----
--1K
---910K
Other net income (expense)
75.00%-2K
113.79%8K
-212.50%-9K
68.37%-62K
-130.77%-4K
-8K
-58K
8K
-189.91%-196K
13K
Other non- operating income (expenses)
75.00%-2K
113.79%8K
-212.50%-9K
68.37%-62K
-130.77%-4K
---8K
---58K
--8K
-189.91%-196K
--13K
Income before tax
-73.39%-20.41M
-62.77%-18.9M
-95.36%-16.93M
-37.14%-48.61M
-97.27%-16.56M
-11.77M
-11.61M
-8.67M
-176.06%-35.44M
-8.39M
Income tax
Net income
-73.39%-20.41M
-62.77%-18.9M
-95.36%-16.93M
-37.14%-48.61M
-97.27%-16.56M
-11.77M
-11.61M
-8.67M
-176.06%-35.44M
-8.39M
Net income continuous Operations
-73.39%-20.41M
-62.77%-18.9M
-95.36%-16.93M
-37.14%-48.61M
-97.27%-16.56M
---11.77M
---11.61M
---8.67M
-176.06%-35.44M
---8.39M
Minority interest income
Net income attributable to the parent company
-73.39%-20.41M
-62.77%-18.9M
-95.36%-16.93M
-37.14%-48.61M
-97.27%-16.56M
-11.77M
-11.61M
-8.67M
-176.06%-35.44M
-8.39M
Preferred stock dividends
129.97%19.19M
57.43%5.94M
5.75M
3.78M
3.73M
50.52%8.35M
3.77M
Other preferred stock dividends
Net income attributable to common stockholders
-16.51%-20.41M
-22.83%-18.9M
-36.54%-16.93M
-54.83%-67.8M
-84.92%-22.49M
-17.51M
-15.39M
-12.4M
-138.20%-43.79M
-12.16M
Basic earnings per share
-8.74%-0.3
-15.51%-0.28
87.43%-0.36
-33.65%-15.65
87.38%-0.3543
-0.2759
-0.2424
-2.8634
-2,046.69%-11.71
-2.8082
Diluted earnings per share
-8.74%-0.3
-15.51%-0.28
87.43%-0.36
-33.65%-15.65
87.38%-0.3543
-0.2759
-0.2424
-2.8634
-2,046.69%-11.71
-2.8082
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 377.78%43K111K172.68%529K6.81%204K1K9K0194K-98.16%191K0
Operating revenue 377.78%43K--111K172.68%529K6.81%204K--1K--9K--0--194K-98.16%191K--0
Cost of revenue
Gross profit
Operating expense 101.67%28.34M110.64%25.96M131.95%23M57.05%55.65M107.79%19.36M14.05M12.33M9.92M54.32%35.44M9.32M
Selling and administrative expenses 276.18%8.72M200.48%7.49M179.21%5.79M54.51%9.9M82.02%3.02M--2.32M--2.49M--2.07M37.95%6.41M--1.66M
-General and administrative expense 276.18%8.72M200.48%7.49M179.21%5.79M54.51%9.9M82.02%3.02M--2.32M--2.49M--2.07M37.95%6.41M--1.66M
Research and development costs 67.21%19.62M87.86%18.47M119.46%17.21M57.61%45.75M113.37%16.34M--11.74M--9.83M--7.84M58.46%29.03M--7.66M
Operating profit -101.49%-28.3M-109.74%-25.85M-131.14%-22.47M-57.32%-55.45M-107.78%-19.36M-14.04M-12.33M-9.72M-179.60%-35.25M-9.32M
Net non-operating interest income expense 245.69%7.89M800.52%6.94M430.21%5.55M690,500.00%6.9M208.13%2.8M2.28M771K1.05M99.78%-1K910K
Non-operating interest income 245.69%7.89M800.52%6.94M430.21%5.55M----------2.28M--771K--1.05M--------
Total other finance cost -------------690,500.00%-6.9M------------------1K---910K
Other net income (expense) 75.00%-2K113.79%8K-212.50%-9K68.37%-62K-130.77%-4K-8K-58K8K-189.91%-196K13K
Other non- operating income (expenses) 75.00%-2K113.79%8K-212.50%-9K68.37%-62K-130.77%-4K---8K---58K--8K-189.91%-196K--13K
Income before tax -73.39%-20.41M-62.77%-18.9M-95.36%-16.93M-37.14%-48.61M-97.27%-16.56M-11.77M-11.61M-8.67M-176.06%-35.44M-8.39M
Income tax
Net income -73.39%-20.41M-62.77%-18.9M-95.36%-16.93M-37.14%-48.61M-97.27%-16.56M-11.77M-11.61M-8.67M-176.06%-35.44M-8.39M
Net income continuous Operations -73.39%-20.41M-62.77%-18.9M-95.36%-16.93M-37.14%-48.61M-97.27%-16.56M---11.77M---11.61M---8.67M-176.06%-35.44M---8.39M
Minority interest income
Net income attributable to the parent company -73.39%-20.41M-62.77%-18.9M-95.36%-16.93M-37.14%-48.61M-97.27%-16.56M-11.77M-11.61M-8.67M-176.06%-35.44M-8.39M
Preferred stock dividends 129.97%19.19M57.43%5.94M5.75M3.78M3.73M50.52%8.35M3.77M
Other preferred stock dividends
Net income attributable to common stockholders -16.51%-20.41M-22.83%-18.9M-36.54%-16.93M-54.83%-67.8M-84.92%-22.49M-17.51M-15.39M-12.4M-138.20%-43.79M-12.16M
Basic earnings per share -8.74%-0.3-15.51%-0.2887.43%-0.36-33.65%-15.6587.38%-0.3543-0.2759-0.2424-2.8634-2,046.69%-11.71-2.8082
Diluted earnings per share -8.74%-0.3-15.51%-0.2887.43%-0.36-33.65%-15.6587.38%-0.3543-0.2759-0.2424-2.8634-2,046.69%-11.71-2.8082
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data